Latest Biotechnology, Pharmaceutical and Healthcare News from PMLIVE

17:35 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "PMLIVE" found in our extensive news archives from over 250 global news sources.

More Information about PMLIVE on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PMLIVE for you to read. Along with our medical data and news we also list PMLIVE Clinical Trials, which are updated daily. BioPortfolio also has a large database of PMLIVE Companies for you to search.

Showing News Articles 1–25 of 953 from PMLIVE

Tuesday 13th November 2018

Roche gains speedy review for Tecentriq in first-line breast cancer

Set to become the first immunotherapy for triple negative breast cancer

Brexit to blame as firm plans to leave UK for Ireland

Tax-inversion deal brought company to UK - now Brexit causes a re-think

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

AZ continues sell-off, SOBI spies US expansion

Duchenne UK backs Evox dystrophin delivery project

Funding will drive preclinical studies on dystrophin-bearing exosomes

Monday 12th November 2018

Key considerations for disease- modifying Parkinson’s disease trials

‘Lessons learnt from Alzheimer’s trials could help in Parkinson’s drug development’

Novartis’ heart failure drug Entresto proves superior to enalapril

Results could see the drug strengthen its position in the market

Gilead NASH drug clears mid-stage trial, but rivals are looming

Positive results to challenge Intercept in emerging disease area

MPs threaten to publish Vertex’s Orkambi price if no deal struck

Gives deadline of 30 November for long-running row to end

Moderna files record $500m IPO for RNA pipeline

Could be the largest IPO for a biotech start-up

Sunday 11th November 2018

Five things you didn't realise you already know about influencer marketing

'When your objective is to build brand loyalty and trust, working with carefully-selected influencers could be the gateway to new audiences'

Friday 9th November 2018

Innovation in merger control and the impact on the pharmaceutical sector

Is focusing on pipeline products enough to assess regulatory risks?

Google boosts healthcare business with new hire

Tech giant shows ambition in US market

Soon-Shiong presents first data on cancer memory vaccine at SITC

Novel cocktail shows modest gains in prostate cancer

MedCity sets up advanced therapy research network

Aims to capitalise on UK's expertise in cutting-edge field

Thursday 8th November 2018

Nudge-nudge, think-think

Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes

Quality in Care Diabetes 2018: the best in innovative diabetes care

Awards highlight new evidence-based approaches to improving care

FDA green lights BMS’ multiple myeloma combo

Speedy approval follows a breakthrough designation

Q&A: Beth Whitworth

Gemma Jones interviews Virgo Health's director

AZ says target of $45bn sales by 2023 still achievable

Q3 revenues topped analyst expectations

BioMarin eyes 2019 FDA filing for haemophilia A gene therapy

Valrox study revealed a 97% reduction in mean annual bleed rates

Wednesday 7th November 2018

The handover: Pfizer reshapes itself for a new era

There is a new leader at the world's biggest pharma company - but just how much is set to change at Pfizer?

GSK among businesses wooed as Brexit reckoning nears

Emma Walmsley to co-chair panel with supermarket CEO

Democrats regain control of House in mid-terms

Biotech and pharma share price indexes have climbed since the news broke

AbbVie sues NHS England over hep C procurement

Accuses NHS of not treating all bidders fairly

Tuesday 6th November 2018

The Final Frontier

Canada’s legalisation of medical cannabis paved the way for recreational cannabis

Quick Search


News Quicklinks